Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB - Wikidata - awgldk - TriplyDB

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

http://www.wikidata.org/entity/Q28201706

about

sameAs

Deubiquitylating enzymes and disease Tumor promoting or tumor suppressing of NF-kB, a matter of cell context dependency The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-κB The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2 TNAP, a novel repressor of NF-kappaB-inducing kinase, suppresses NF-kappaB activation Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8 Emerging roles for the non-canonical IKKs in cancer The tumor suppressor CYLD regulates entry into mitosis Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53 The translation initiation factor 3f (eIF3f) exhibits a deubiquitinase activity regulating Notch activation Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation The IkappaB kinase complex: master regulator of NF-kappaB signaling CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation Suppression of cancer cell growth by promoting cyclin D1 degradation Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6 Distinct regulation of Ubc13 functions by the two ubiquitin-conjugating enzyme variants Mms2 and Uev1A Regulation of MITF stability by the USP13 deubiquitinase USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity TRAF family proteins link PKR with NF-kappa B activation Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2 siRNA-mediated off-target gene silencing triggered by a 7 nt complementation Global approaches to understanding ubiquitination.Poly-ubiquitination in TNFR1-mediated necroptosis Regulation of Met1-linked polyubiquitin signalling by the deubiquitinase OTULIN Molecular basis of hypohidrotic ectodermal dysplasia: an update Ubiquitin in the immune system Regulation of NF-κB by ubiquitination PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation Deubiquitination, a new player in Golgi to endoplasmic reticulum retrograde transport.The Rsp5 ubiquitin ligase is coupled to and antagonized by the Ubp2 deubiquitinating enzyme.

P2860

Q21284381-6055A45E-0B2F-42AE-8A00-57628E2C63A0 Q23912835-13D61748-3D82-4D09-9B5F-3C84386B1FDE Q24294960-2936AB06-E362-42A0-AD07-78B72E7D6D02 Q24296068-ECDA65BF-7A4D-4ACD-A5AA-10B6A8264F79 Q24296502-6F3676F1-3CA2-4085-95F9-CEFAADC5C67A Q24297399-AAD2E74B-350B-4137-BA84-F7340D1E72C4 Q24299892-7A7D00A4-5473-4B63-A0D3-C0D52F7E37A2 Q24301536-337564E4-8F58-4C45-91A9-B65F87BF78F7 Q24305225-881E4CB7-B7C9-453E-8EF7-581955C7447B Q24305326-89B60557-678D-4FB9-AF45-5855FDA23614 Q24309310-0DE3D064-73DE-4B2A-A822-C3A5E693E298 Q24310748-D08AF6A6-E1B3-4602-AB9A-7E7695BC7283 Q24311308-0102E288-E9CD-42E3-B2E4-D54B08E7A953 Q24313366-B1BB3AA2-08A1-47EB-8877-9DF47445AFB8 Q24314876-2968F992-5ECE-4814-9B83-1B13BEF0505E Q24314946-3C9CD400-FBB5-4A49-9E3F-1A52C6CDB89D Q24315943-749593F4-574B-4178-B9A4-0E99239A935D Q24317660-267CAB20-31FB-44D0-9D3F-079BD2D4B6FF Q24318345-BC04E10A-3A97-4A92-989E-C2DB38A9D5A1 Q24318789-CF0F9E3C-A70F-482A-8A0E-2DF015EAB556 Q24318832-6C2E0DD0-437E-4FE6-8F41-0598D9C42C94 Q24328791-2D42D4D5-D0F8-4F26-AE81-97E6D6C56C78 Q24337169-C49F4008-9CF6-4FB3-8145-981DC1194957 Q24338458-475B33C0-63BA-49E2-894A-3F5BA91812EB Q24530708-094ED891-524A-4D17-A5DA-E0B551CA87F9 Q24622802-511AA0DB-1589-489B-BE97-D7BFB1D69C8B Q24629378-57D24D03-4B57-4229-861E-45F9D12D20D5 Q24672820-094AE686-27EA-4DE0-9397-62D97B6926FF Q24684757-8ED5DA53-979A-437A-BCB1-404CDD14F26C Q24812419-B5B2A43A-F372-47F7-AA9B-56CDBDDD44D4 Q24812618-E7D77245-DAF6-498F-8449-E7C67CD8BEB1 Q26749315-20E81DB3-D368-4609-8681-333B7EDC438E Q26778774-A0BBD74F-4477-4F29-962B-239D733DE89F Q26796229-0E28C3F0-4F2A-4DAB-800C-8699D1397AD6 Q26998711-E740B5B6-D8C3-493A-9368-5E255C711753 Q27024099-2E12194D-7329-4632-B7EC-8A203DD1BE64 Q27320965-2A318F5C-6513-45FB-BBEC-0AD9A6883035 Q27674024-2CE7D6CE-278C-430C-9416-1243DF46639A Q27932593-37F420CF-894C-47EA-92E2-5CBAD094DDF3 Q27933628-96256C12-0A3F-48BD-ADB6-C015F97A6CEE

P2860

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

http://www.wikidata.org/entity/Q28201706

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

@ast

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

@en

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

@nl

type

label

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

@ast

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

@en

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

@nl

prefLabel

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

@ast

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

@en

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

@nl

P1433

Q28201706-77604907-C988-412D-8D12-AE0D2B3806FC

P1476

Q28201706-E5F4CF10-4702-4A34-A93E-CCA9D46375A7

P2093

Q28201706-19CFE14E-01CB-439E-807C-DF58AE28EB9F

Q28201706-52D7654F-69F6-4DDC-851D-BA55DE5E74A3

Q28201706-E6F3AFB3-0065-4F6E-A0DF-AE4D41398CEE

P2860

Q28201706-054216C9-DF66-49E8-A180-DE4328D4AFA0

Q28201706-05B55832-0B52-484C-A133-57A3C96F5F23

Q28201706-0D5C7360-AB79-4DF0-9C57-4CA203FB4D27

Q28201706-19840228-D956-4FA1-B13E-001F9587DD01

Q28201706-28AF2F16-72C2-4038-9668-D5FD825BA7A1

Q28201706-32669AE8-AEBA-43D0-899A-2C0747C451E3

Q28201706-332A7DE2-EAF0-41F2-8377-88AB26CB8C1D

Q28201706-3FAC997E-B56A-464C-9E41-288152A6B4A2

Q28201706-4CE3A941-B088-4CF4-B42B-4BE5ED21F76C

Q28201706-4DED0E26-367A-485E-AFA3-1A7DAE8F428B

P2888

Q28201706-8972E928-7881-4A89-86A8-D2117883AB4E

P304

Q28201706-B9A8E3EB-C8E1-4470-B6D6-7AE92E5BC9AA

P31

Q28201706-7D0E1EDA-F767-4ABE-8AD8-79E348468C65

P3181

Q28201706-C24A2810-F7BA-40E9-A605-B0CDC62458DB

P356

Q28201706-52C463F4-4E29-4515-ADE9-93871AE77572

P407

Q28201706-99ED4521-F160-4542-A04C-A15BCAD40882

P433

Q28201706-669B3B6C-5B74-4973-A335-A07BDB407BEE

P478

Q28201706-BC300E8F-B007-4462-A480-EC13A51F89D7

P50

Q28201706-5AA637ED-635A-40F8-8EA2-5DDAF2087153

P577

Q28201706-8F40449F-D851-44EC-BD44-13FBD419AF15

P5875

Q28201706-7561A75F-97BD-467B-A050-E46904F0592D

P6179

Q28201706-4C4711D9-0BFB-4D9A-8122-8921B7F0F87E

P698

Q28201706-8EFE2E29-31F5-4217-AF8C-1D2E8775FAD9

P921

Q28201706-41B67034-431A-4997-811C-714F5ADC8C55

Q28201706-F229BECB-4DA1-41D4-81A0-754CABC63285

P3181

P356

P1433

P1476

Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB

@en

P2093

Annette M G Dirac

http://www.w3.org/2001/XMLSchema#string

Sebastian M B Nijman

http://www.w3.org/2001/XMLSchema#string

Thijn R Brummelkamp

http://www.w3.org/2001/XMLSchema#string

P2860

Deubiquitinating enzymes: a new class of biological regulators

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

A system for stable expression of short interfering RNAs in mammalian cells

The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene.

Identification of the familial cylindromatosis tumour-suppressor gene

Tumor necrosis factor receptor-associated factors (TRAFs)

CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members

TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90

NF-kappaB in cancer: from innocent bystander to major culprit

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

P2888

P304

797-801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1589686

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE01811

http://www.w3.org/2001/XMLSchema#string

P407

P433

6950

http://www.w3.org/2001/XMLSchema#string

P478

424

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10613896

http://www.w3.org/2001/XMLSchema#string

P6179

1026687985

http://www.w3.org/2001/XMLSchema#string

P698

12917690

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process